Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dor Breier

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Bioactive Materials|October 3, 2022
Genome editing in cancer: Challenges and potential opportunitiesDor Breier, Dan Peer
Cell Reports. Medicine|January 7, 2025
Delivery of genetic medicines for muscular dystrophiesYulia Chulanova, Dor Breier, Dan Peer
Nature Biomedical Engineering|October 24, 2024
Immunogenic amines on lipid nanoparticlesPreeti Sharma, Dor Breier, Dan Peer
Advanced Drug Delivery Reviews|January 13, 2024
The immunostimulatory nature of mRNA lipid nanoparticlesPreeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Molecular Therapy. Nucleic Acids|June 27, 2024
Unlocking the therapeutic potential of locked nucleic acids through lipid nanoparticle deliveryShahd Qassem, Dor Breier, Gonna Somu Naidu, et al.
ACS Nano|February 6, 2025
Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung TumorsGonna Somu Naidu, Riccardo Rampado, Preeti Sharma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 25, 2024
Lipid Nanoparticles With Fine-Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA TherapeuticsRiccardo Rampado, Gonna Somu Naidu, Olga Karpov, et al.
Molecular Therapy. Nucleic Acids|January 9, 2023
Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCsOrtal Iancu, Daniel Allen, Orli Knop, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 30, 2024
Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck CancerRazan Masarwy, Dor Breier, Lior Stotsky-Oterin, et al.
Molecular Therapy. Nucleic Acids|May 25, 2026
Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCsOrli Knop, Nimrod Ben Haim, Nechama Kalter, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bioactive Materials|October 3, 2022
Genome editing in cancer: Challenges and potential opportunitiesDor Breier, Dan Peer
Cell Reports. Medicine|January 7, 2025
Delivery of genetic medicines for muscular dystrophiesYulia Chulanova, Dor Breier, Dan Peer
Nature Biomedical Engineering|October 24, 2024
Immunogenic amines on lipid nanoparticlesPreeti Sharma, Dor Breier, Dan Peer
Advanced Drug Delivery Reviews|January 13, 2024
The immunostimulatory nature of mRNA lipid nanoparticlesPreeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Molecular Therapy. Nucleic Acids|June 27, 2024
Unlocking the therapeutic potential of locked nucleic acids through lipid nanoparticle deliveryShahd Qassem, Dor Breier, Gonna Somu Naidu, et al.
ACS Nano|February 6, 2025
Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung TumorsGonna Somu Naidu, Riccardo Rampado, Preeti Sharma, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 25, 2024
Lipid Nanoparticles With Fine-Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA TherapeuticsRiccardo Rampado, Gonna Somu Naidu, Olga Karpov, et al.
Molecular Therapy. Nucleic Acids|January 9, 2023
Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCsOrtal Iancu, Daniel Allen, Orli Knop, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 30, 2024
Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck CancerRazan Masarwy, Dor Breier, Lior Stotsky-Oterin, et al.
Molecular Therapy. Nucleic Acids|May 25, 2026
Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCsOrli Knop, Nimrod Ben Haim, Nechama Kalter, et al.
Pageof 2